These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 36199476)

  • 1. The Mucoadhesive Nanoparticle-Based Delivery System in the Development of Mucosal Vaccines.
    Zhao K; Xie Y; Lin X; Xu W
    Int J Nanomedicine; 2022; 17():4579-4598. PubMed ID: 36199476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
    Jin Z; Gao S; Cui X; Sun D; Zhao K
    Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
    Bento D; Staats HF; Gonçalves T; Borges O
    Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal Vaccine Delivery Using Mucoadhesive Polymer Particulate Systems.
    Cho CS; Hwang SK; Gu MJ; Kim CG; Kim SK; Ju DB; Yun CH; Kim HJ
    Tissue Eng Regen Med; 2021 Oct; 18(5):693-712. PubMed ID: 34304387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery.
    Lin Y; Sun B; Jin Z; Zhao K
    ACS Appl Mater Interfaces; 2022 Nov; 14(47):52691-52701. PubMed ID: 36382954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chrysanthemum sporopollenin: A novel vaccine delivery system for nasal mucosal immunity.
    Liu J; Yan XD; Li XQ; Du YH; Zhu LL; Ye TT; Cao ZY; Dong ZW; Li ST; Xu X; Bai W; Li D; Zhang JW; Wang SJ; Li SH; Sun J; Yin XZ
    Front Immunol; 2023; 14():1132129. PubMed ID: 36845130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
    Pawar D; Mangal S; Goswami R; Jaganathan KS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.
    Mishra N; Goyal AK; Tiwari S; Paliwal R; Paliwal SR; Vaidya B; Mangal S; Gupta M; Dube D; Mehta A; Vyas SP
    Expert Opin Ther Pat; 2010 May; 20(5):661-79. PubMed ID: 20345332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers.
    Garg NK; Mangal S; Khambete H; Tyagi RK
    Recent Pat Drug Deliv Formul; 2010 Jun; 4(2):114-28. PubMed ID: 20380624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal Adjuvants Delivered by a Mucoadhesive Patch for Sublingual Administration of Subunit Vaccines.
    Monge C; Ayad C; Paris AL; Rovera R; Colomb E; Verrier B
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
    Pawar D; Jaganathan KS
    Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer nanotechnology based approaches in mucosal vaccine delivery: challenges and opportunities.
    Sharma R; Agrawal U; Mody N; Vyas SP
    Biotechnol Adv; 2015; 33(1):64-79. PubMed ID: 25499178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7-Adjuvanted Vaginal Vaccine Elicits Strong Mucosal Immune Responses in Non-Human Primates.
    Logerot S; Figueiredo-Morgado S; Charmeteau-de-Muylder B; Sandouk A; Drillet-Dangeard AS; Bomsel M; Bourgault-Villada I; Couëdel-Courteille A; Cheynier R; Rancez M
    Front Immunol; 2021; 12():614115. PubMed ID: 33717097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal vaccine design and delivery.
    Woodrow KA; Bennett KM; Lo DD
    Annu Rev Biomed Eng; 2012; 14():17-46. PubMed ID: 22524387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
    Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
    APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like Receptor-4 (TLR4) Agonist-Based Intranasal Nanovaccine Delivery System for Inducing Systemic and Mucosal Immunity.
    Bakkari MA; Valiveti CK; Kaushik RS; Tummala H
    Mol Pharm; 2021 Jun; 18(6):2233-2241. PubMed ID: 34010002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-based Nanoparticles in Mucosal Vaccine Delivery.
    Mehrabi M; Montazeri H; Mohamadpour Dounighi N; Rashti A; Vakili-Ghartavol R
    Arch Razi Inst; 2018 Sep; 73(3):165-176. PubMed ID: 30280836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of mucosal immunity through systemic immunization: Phantom or reality?
    Su F; Patel GB; Hu S; Chen W
    Hum Vaccin Immunother; 2016 Apr; 12(4):1070-9. PubMed ID: 26752023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines, adjuvants and key factors for mucosal immune response.
    Correa VA; Portilho AI; De Gaspari E
    Immunology; 2022 Oct; 167(2):124-138. PubMed ID: 35751397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced mucosal and systemic immune responses to a vaginal vaccine coadministered with RANTES-expressing plasmid DNA using in situ-gelling mucoadhesive delivery system.
    Oh YK; Park JS; Yoon H; Kim CK
    Vaccine; 2003 May; 21(17-18):1980-8. PubMed ID: 12706687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.